Number and proportion of predicted mHAs by HLA allele within the study population. mHAs classified as “GVL” broadly represent mHAs that are desirable to target for antileukemia effects with minimal GVHD. mHAs classified as “GVH” represent mHAs that are undesirable to target as they are predicted to correspond to GVHD and have no GVL effects. The “both” category represents peptides that are predicted to lead to both GVL and GVH effects. (A) Shows counts of each predicted class of mHA for HLA-A alleles represented in the patient data set. (B) Shows counts for HLA-B alleles represented in the patient data set. (C) Shows counts for HLA-C alleles represented in the patient data set. (D) Shows the proportion of predicted mHAs corresponding to each mHA class for HLA-A alleles. (E) Shows the proportion for HLA-B alleles. (F) Shows the proportion of HLA-C alleles.